作者
Ina Rosenberger, Christian Schmithals, Jennifer Vandooren, Silvia Bianchessi, Paolo Milani, Erica Locatelli, Liron L Israel, Frank Hübner, Michela Matteoli, Jean-Paul Lellouche, Mauro Comes Franchini, Lorena Passoni, Eugenio Scanziani, Ghislain Opdenakker, Albrecht Piiper, Jörg Kreuter
发表日期
2014/11/28
期刊
Journal of controlled release
卷号
194
页码范围
130-137
出版商
Elsevier
简介
Iron oxide-containing magnetic nanoparticles (MNPs) have certain advantages over currently used contrast agents for tumor imaging by magnetic resonance imaging (MRI) as they offer the possibility of functionalization with ligands and tracers. Functionalized MNPs also may be used for targeted tumor therapy. In the current study nanoparticles (NPs) consisting of recombinant human serum albumin (rHSA) with incorporated hydrophilic (NH4)2Ce(IV)(NO3)6-γ-Fe2O3 particles (CAN maghemite particles) for medical imaging were produced and characterized. For this purpose CAN maghemite particles were incorporated into an rHSA matrix to yield rHSA-NPs. The resulting NPs were analyzed by transmission electron microscopy, photon correlation spectroscopy, and atomic absorption. The sizes of the manufactured NP were 170 ± 10 nm, and the zeta-potential was − 50 ± 3 mV. The NPs remained stable when …
引用总数
2015201620172018201920202021202220232024626231412